Valuation: DexCom, Inc.

Market Cap 33.87B 177B 29.25B 27.49B 25B 47B 3,239B 47.77B 322B 126B 1,622B 127B 124B 5,389B P/E 2026 *
36x
P/E 2027 * 30.2x
Enterprise Value 33.11B 173B 28.59B 26.87B 24.44B 45.94B 3,166B 46.7B 315B 123B 1,585B 124B 122B 5,268B EV / Sales 2026 *
6.33x
EV / Sales 2027 * 5.66x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day+1.19%
1 week+8.81%
Current month+10.73%
1 month+18.26%
3 months+44.46%
6 months+23.23%
Current year+25.37%
1 week 8.65
Extreme 8.65
9.57
1 month 7.01
Extreme 7.01
9.57
Current year 5.75
Extreme 5.75
9.57
1 year 5.75
Extreme 5.75
9.57
3 years 5.75
Extreme 5.75
14.45
5 years 5.75
Extreme 5.75
18.3
10 years 5.75
Extreme 5.75
18.3
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
+1.19%+8.81% - - 34.52B
-0.02%+3.05%-14.03%+5.64% 193B
+0.76%+6.23%-1.77%+9.37% 116B
+1.43%-3.44%+7.83%+67.49% 59.16B
+0.32%+4.59%+34.37%+62.62% 55.75B
+0.79%+3.57%-6.41%-35.04% 49.57B
-1.89%+8.11%+12.24%-19.64% 34.52B
+0.45%+3.56% - - 31.22B
+0.94%+0.24%+41.91%-11.48% 24.36B
+1.98%+15.59%-4.40%+22.62% 24.25B
Average +0.59%+4.09%+8.72%+12.70% 65.26B
Weighted average by Cap. +0.46%+3.53%+0.89%+13.50%

Financials

2026 *2027 *
Net sales 5.23B 27.37B 4.52B 4.24B 3.86B 7.26B 500B 7.38B 49.74B 19.45B 250B 19.64B 19.21B 832B 5.8B 30.35B 5.01B 4.71B 4.28B 8.05B 555B 8.18B 55.15B 21.56B 278B 21.78B 21.3B 923B
Net income 974M 5.1B 842M 791M 719M 1.35B 93.17B 1.37B 9.27B 3.62B 46.66B 3.66B 3.58B 155B 1.15B 6.01B 992M 932M 848M 1.59B 110B 1.62B 10.93B 4.27B 55.02B 4.31B 4.22B 183B
Net Debt -761M -3.98B -657M -618M -562M -1.06B -72.78B -1.07B -7.24B -2.83B -36.45B -2.86B -2.8B -121B -1.06B -5.55B -917M -862M -783M -1.47B -102B -1.5B -10.09B -3.95B -50.83B -3.99B -3.9B -169B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
13/08/26 BRL 9.470 +2.05% 14,264
12/08/26 BRL 9.280 +0.32% 364
11/08/26 BRL 9.250 +3.01% 1,028
10/08/26 BRL 8.980 +4.06% 170
07/08/26 BRL 8.630 +1.65% 355
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
89.75USD
Average target price
94.12USD
Spread / Average Target
+4.87%

Quarterly revenue - Rate of surprise